Effect of FK506 (tacrolimus) in animal models of inflammation

Author： Singh Amanpreet   Naidu Pattipati S.   Patil C. S.   Kulkarni Shrinivas K.  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.11, Iss.3, 2003-09, pp. : 249-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible inhibitory mechanism of FK506 (tacrolimus hydrate) ointment for atopic dermatitis based on animal models

By Sengoku T.   Morita K.   Sakuma S.   Motoyama Y.   Goto T.  

European Journal of Pharmacology, Vol. 379, Iss. 2, 1999-08 ,pp. : 183-189

Elsevier

Access to resources Recommend Favorite

Protective effect of FK506 (Tacrolimus) in pentylenetetrazol-induced kindling in mice

By Singh A.   Kumar G.   Naidu P.S.   Kulkarni S.K.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 853-860

Elsevier

Access to resources Recommend Favorite

In vitro–in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 5, 2015-07 ,pp. : 265-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats

By Fujii Y.   Takeuchi H.   Tanaka K.   Sakuma S.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 456, Iss. 1, 2002-12 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

FK506 (tacrolimus) increases rat 1 -acid glycoprotein expression in liver and primary cultured hepatocytes

By Shimoishi K.   Kai H.   Kabu K.   Komori T.   Maruyama T.   Otagiri M.  

European Journal of Pharmacology, Vol. 420, Iss. 2, 2001-05 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite